Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450944
Status:
COMPLETED
Last Update Posted:
2021-04-14
First Post:
2007-03-20
Brief Title:
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Sponsor:
Albert Einstein College of Medicine
Organization:
Albert Einstein College of Medicine
Organization Data
Organization:
Albert Einstein College of Medicine
Class:
OTHER
Study ID:
2005-536
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Albert Einstein College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |